Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Advances in Experimental Medicine and Biology|July 21, 2021
CCL25 Signaling in the Tumor MicroenvironmentHina Mir, Shailesh SinghProgress in Molecular Biology and Translational Science|November 4, 2017
Association of Cytokines and Chemokines in Pathogenesis of Breast CancerJeronay King, Hina Mir, Shailesh SinghCancers|November 27, 2019
Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate CancerJeronay King Thomas, Hina Mir, Neeraj Kapur, et al.Cancer Cell International|April 24, 2019
Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathwaysIan T Saunders, Hina Mir, Neeraj Kapur, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 22, 2025
Elevated CCL20 and IL-10 enhance 5-fluorouracil tolerance in colon cancerJanani Muralidharan, Murugesh Eswaran, Sejong Bae, et al.Scientific Reports|March 10, 2019
CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survivalJeronay K Thomas, Hina Mir, Neeraj Kapur, et al.Oncotarget|April 19, 2015
CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinasesHina Mir, Rajesh Singh, Goetz H Kloecker, et al.International Journal of Oncology|August 2, 2018
Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancerPatrick P Carriere, Neeraj Kapur, Hina Mir, et al.Cell Cycle (Georgetown, Tex.)|April 1, 2016
Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptorsHina Mir, Neeraj Kapur, Rajesh Singh, et al.Scientific Reports|February 23, 2019
Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulationHina Mir, Gurpreet Kaur, Neeraj Kapur, et al.Pageof 9